CRL vs. ILMN
Compare and contrast key facts about Charles River Laboratories International, Inc. (CRL) and Illumina, Inc. (ILMN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CRL or ILMN.
Correlation
The correlation between CRL and ILMN is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CRL vs. ILMN - Performance Comparison
Loading data...
Key characteristics
CRL:
-0.70
ILMN:
-0.58
CRL:
-0.87
ILMN:
-0.67
CRL:
0.87
ILMN:
0.92
CRL:
-0.50
ILMN:
-0.30
CRL:
-1.43
ILMN:
-1.02
CRL:
27.54%
ILMN:
25.15%
CRL:
53.84%
ILMN:
43.17%
CRL:
-78.23%
ILMN:
-96.14%
CRL:
-69.24%
ILMN:
-83.62%
Fundamentals
CRL:
$6.92B
ILMN:
$13.24B
CRL:
-$0.62
ILMN:
-$6.08
CRL:
0.12
ILMN:
0.62
CRL:
1.72
ILMN:
3.05
CRL:
2.14
ILMN:
5.41
CRL:
$4.02B
ILMN:
$4.34B
CRL:
$1.28B
ILMN:
$2.88B
CRL:
$546.00M
ILMN:
-$465.00M
Returns By Period
In the year-to-date period, CRL achieves a -23.63% return, which is significantly higher than ILMN's -37.42% return. Over the past 10 years, CRL has outperformed ILMN with an annualized return of 6.90%, while ILMN has yielded a comparatively lower -8.21% annualized return.
CRL
-23.63%
32.93%
-24.91%
-36.39%
-3.89%
6.90%
ILMN
-37.42%
17.44%
-38.08%
-22.61%
-24.29%
-8.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CRL vs. ILMN — Risk-Adjusted Performance Rank
CRL
ILMN
CRL vs. ILMN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Charles River Laboratories International, Inc. (CRL) and Illumina, Inc. (ILMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CRL vs. ILMN - Dividend Comparison
Neither CRL nor ILMN has paid dividends to shareholders.
Drawdowns
CRL vs. ILMN - Drawdown Comparison
The maximum CRL drawdown since its inception was -78.23%, smaller than the maximum ILMN drawdown of -96.14%. Use the drawdown chart below to compare losses from any high point for CRL and ILMN. For additional features, visit the drawdowns tool.
Loading data...
Volatility
CRL vs. ILMN - Volatility Comparison
Charles River Laboratories International, Inc. (CRL) has a higher volatility of 19.98% compared to Illumina, Inc. (ILMN) at 13.97%. This indicates that CRL's price experiences larger fluctuations and is considered to be riskier than ILMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CRL vs. ILMN - Financials Comparison
This section allows you to compare key financial metrics between Charles River Laboratories International, Inc. and Illumina, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRL vs. ILMN - Profitability Comparison
CRL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Charles River Laboratories International, Inc. reported a gross profit of 317.73M and revenue of 984.17M. Therefore, the gross margin over that period was 32.3%.
ILMN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported a gross profit of 683.00M and revenue of 1.04B. Therefore, the gross margin over that period was 65.6%.
CRL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Charles River Laboratories International, Inc. reported an operating income of 74.67M and revenue of 984.17M, resulting in an operating margin of 7.6%.
ILMN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported an operating income of 164.00M and revenue of 1.04B, resulting in an operating margin of 15.8%.
CRL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Charles River Laboratories International, Inc. reported a net income of 25.47M and revenue of 984.17M, resulting in a net margin of 2.6%.
ILMN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported a net income of 131.00M and revenue of 1.04B, resulting in a net margin of 12.6%.